Zimbabwe has declined a major American health deal worth $367m (272 million pounds) over five years over Washington's insistence on sensitive information.
This rejection became public after a official document from December was leaked, revealing that Head of State Emmerson Mnangagwa believed the deal was "unbalanced".
A government spokesperson later clarified that the US was demanding access to health data for scientific study and commercial purposes while was unwilling to share the resulting advantages from any future treatments.
"We will now turn to the difficult and regrettable process of winding down our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had provided over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has appealed for further dialogue to reach a deal agreeable to all parties so the country's critical HIV treatment initiative can be sustained.
Broader Context
Zimbabwe's decision follows a similar case in neighbouring Kenya, where a court suspended a related health funding agreement following concerns were filed about the security of Kenyans' health data.
After resuming office last year, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
USAID had overseen assistance for the American government, but Trump argued its expenditure was "inefficient" and his administration was seeking government-to-government agreements to enhance transparency and accountability.
According to statements, Sixteen nations in Africa have so far agreed to similar agreements, constituting over $18.3bn in committed funds.
Details of the Rejected Agreement
The money for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this cooperation would have delivered immense benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on antiretroviral therapy via US-supported initiatives," the Ambassador added.
However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".
"The proposal required Zimbabwe to share its biological resources and data over an extended period, with no corresponding assurance of access to any medical innovations – like vaccines, diagnostics, or treatments – that could be developed from that shared data," his statement read.
"In essence, our nation would supply the basic resources for medical research without any assurance that the final treatments would be available to our citizens should a new pandemic arise."
National Interest and Global Health
He also said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting systems already set up through the global health agency.
Mangwana cited its Pandemic Benefit-Sharing system created to deal with future global health emergencies.
"This mechanism is designed to ensure that when a nation provides its samples, the resulting advantages – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the resources to create them."
Zimbabwe's reservations over the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We are open to continued dialogue with our American counterparts on how subsequent co-operation might be designed in a way that honours the independence and dignity of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the government's concerns, but urged that talks must proceed given that much of the country's HIV programmes were funded by international support.
"In cases where technical issues arise, including those relating to data governance or agreement terms, these can often be addressed through detailed discussion and mutually agreed protections," the group added.
The halted deal underscores the ongoing debate between accepting crucial foreign assistance and protecting local interests in an ever more data-driven world.